Meperidine to control shivering associated with platelet transfusion reaction.
Shivering may be part of a febrile non-haemolytic reaction to blood product transfusion. Shivering can increase oxygen consumption up to 500 per cent which may be detrimental to patients with decreased myocardial reserve. A case is presented of a reaction to platelet transfusion characterized by shivering, tachycardia and hypertension in a patient with a recent myocardial infarction in whom the metabolic and haemodynamic effects were considered to be potentially disastrous. Intravenous injection of meperidine was rapidly effective in treating these changes.
Department of Anaesthesia, St. Michael's Hospital, University of Toronto, Ontario.
M
M
Friedlander
W H
WH
Noble
D000328:Adult; D006801:Humans; D008297:Male; D008614:Meperidine / Q000627:therapeutic use*; D017713:Platelet Transfusion; D012768:Shivering / Q000187:drug effects*; D065227:Transfusion Reaction
D008614:Meperidine